Terms: = Breast cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4
79 results:
1. Construction of a prognostic model for triple-negative breast cancer based on immune-related genes, and associations between the tumor immune microenvironment and immunological therapy.
Zhu Y; Tao LF; Liu JY; Wang YX; Huang H; Jiang YN; Qian WF
Cancer Med; 2023 Jul; 12(14):15704-15719. PubMed ID: 37306188
[TBL] [Abstract] [Full Text] [Related]
2. WNT3a Signaling Inhibits Aromatase Expression in breast Adipose Fibroblasts-A Possible Mechanism Supporting the Loss of Estrogen Responsiveness of Triple-Negative breast cancers.
Kaiser A; Eiselt G; Bechler J; Huber O; Schmidt M
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902090
[TBL] [Abstract] [Full Text] [Related]
3. Genotypes and Haplotypes in the
Rosales-Reynoso MA; Rosas-Enríquez V; Saucedo-Sariñana AM; Pérez-Coria M; Gallegos-Arreola MP; Salas-González E; Barros-Núñez P; Juárez-Vázquez CI; Flores-Martínez SE; Sánchez-Corona J
Br J Biomed Sci; 2022; 79():10211. PubMed ID: 35996498
[No Abstract] [Full Text] [Related]
4. Development of a Novel Immune-Related Gene Prognostic Index for breast cancer.
Yao Y; Kong X; Liu R; Xu F; Liu G; Sun C
Front Immunol; 2022; 13():845093. PubMed ID: 35558081
[TBL] [Abstract] [Full Text] [Related]
5. Increased risk of secondary lung cancer in patients with tuberculosis: A nationwide, population-based cohort study.
Ho LJ; Yang HY; Chung CH; Chang WC; Yang SS; Sun CA; Chien WC; Su RY
PLoS One; 2021; 16(5):e0250531. PubMed ID: 33961650
[TBL] [Abstract] [Full Text] [Related]
6. Involvement of β-catenin in Androgen-induced Mesenchymal Transition of breast MDA-MB-453 cancer Cells.
Ahram M; Bawadi R; Abdullah MS; Alsafadi DB; Abaza H; Abdallah S; Mustafa E
Endocr Res; 2021 Aug; 46(3):114-128. PubMed ID: 33703980
[No Abstract] [Full Text] [Related]
7. Circ-PRMT5 promotes breast cancer by the miR-509-3p/tcf7l2 axis activating the PI3K/AKT pathway.
Wu D; Jia H; Zhang Z; Li S
J Gene Med; 2021 Feb; 23(2):e3300. PubMed ID: 33277756
[TBL] [Abstract] [Full Text] [Related]
8. A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.
Zheng K; Wan H; Zhang J; Shan G; Chai N; Li D; Fang N; Liu L; Zhang J; Du R; Wu Q; Li X; Zhang C
J Transl Med; 2020 May; 18(1):215. PubMed ID: 32466784
[TBL] [Abstract] [Full Text] [Related]
9. The Wnt3a/β-catenin/tcf7l2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.
Shen G; Gao Q; Liu F; Zhang Y; Dai M; Zhao T; Cheng M; Xu T; Jin P; Yin W; Huang D; Weng H; Chen W; Ren H; Mu X; Wu X; Hu S
Biochem Biophys Res Commun; 2020 Jun; 526(3):685-691. PubMed ID: 32248976
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with tcf7l2.
Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
[TBL] [Abstract] [Full Text] [Related]
11. Cullin7 enhances resistance to trastuzumab therapy in Her2 positive breast cancer via degrading IRS-1 and downregulating IGFBP-3 to activate the PI3K/AKT pathway.
Qiu N; He YF; Zhang SM; Zhan YT; Han GD; Jiang M; He WX; Zhou J; Liang HL; Ao X; Xia HM; Li J; Yang YY; He ZM; Zou ZZ; Li HS
Cancer Lett; 2019 Nov; 464():25-36. PubMed ID: 31461670
[TBL] [Abstract] [Full Text] [Related]
12. Genome-wide mapping of DNA-binding sites identifies stemness-related genes as directly repressed targets of SNAIL1 in colorectal cancer cells.
Beyes S; Andrieux G; Schrempp M; Aicher D; Wenzel J; Antón-García P; Boerries M; Hecht A
Oncogene; 2019 Oct; 38(40):6647-6661. PubMed ID: 31391555
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNA LUCAT1/miR-5582-3p/tcf7l2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract] [Full Text] [Related]
14. Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling.
Gupta N; Srivastava SK
Mol Cancer Ther; 2019 Oct; 18(10):1708-1720. PubMed ID: 31270151
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
[TBL] [Abstract] [Full Text] [Related]
16. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
Yu X; Wang M; Wu J; Han Q; Zhang X
J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
[TBL] [Abstract] [Full Text] [Related]
17. Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing.
Mizugaki H; Hamada A; Shibata T; Hosoda F; Nakamura H; Okuma Y; Shukuya T; Umemura S; Horiike A; Fukui T; Kogure Y; Daga H; Urata Y; Yamada K; Saeki S; Fujisaka Y; Nakamura Y; Sato M; Yoshida T; Hotta T; Oizumi S; Fujiwara Y; Ohe Y; Fujiwara Y
Lung Cancer; 2019 Feb; 128():20-25. PubMed ID: 30642448
[TBL] [Abstract] [Full Text] [Related]
18. The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative breast cancer.
El Ayachi I; Fatima I; Wend P; Alva-Ornelas JA; Runke S; Kuenzinger WL; Silva J; Silva W; Gray JK; Lehr S; Barch HC; Krutilina RI; White AC; Cardiff R; Yee LD; Yang L; O'Regan RM; Lowry WE; Seagroves TN; Seewaldt V; Krum SA; Miranda-Carboni GA
Cancer Res; 2019 Mar; 79(5):982-993. PubMed ID: 30563890
[TBL] [Abstract] [Full Text] [Related]
19. CD147 (EMMPRIN) controls malignant properties of breast cancer cells by interdependent signaling of Wnt and JAK/STAT pathways.
Knutti N; Huber O; Friedrich K
Mol Cell Biochem; 2019 Jan; 451(1-2):197-209. PubMed ID: 30022447
[TBL] [Abstract] [Full Text] [Related]
20. Bioinformatics analysis of differentially expressed miRNA-related mRNAs and their prognostic value in breast carcinoma.
Zhang GM; Goyal H; Song LL
Oncol Rep; 2018 Jun; 39(6):2865-2872. PubMed ID: 29693181
[TBL] [Abstract] [Full Text] [Related]
[Next]
